The U.S. Food and Drug Administration (FDA) has granted fast track designation to Dyscorban (ifetroban), Cumberland Pharmaceuticals’ treatment…
Articles by Andrea Lobo
A research collaboration led by the Muscular Dystrophy Association (MDA) aims to create a molecular map of human muscle…
The Muscular Dystrophy Association (MDA) has announced the agenda for its 2026 MDA Clinical & Scientific Conference —…
A combined regimen of testosterone and growth hormone led to significant improvements in muscle mass, strength, and mobility in men…
Long-term treatment with Duvyzat (givinostat) delays the loss of key motor skills in people with Duchenne muscular dystrophy…
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to ISX9-CPC, IPS Heart’s experimental stem cell…
Solve FSH, a venture philanthropic organization, has invested $3 million to support the development of Armatus Bio‘s microRNA-based…
CureDuchenne will host its annual Futures National Conference May 22-25 in San Antonio, as part of an effort…
Health Canada has agreed to review an application by Kye Pharmaceuticals seeking the approval of vamorolone for treating…
An independent data monitoring committee (DMC) favors continuing dosing Elevidys (delandistrogene moxeparvovec-rokl) to people with Duchenne muscular dystrophy…